{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T15:51:17Z","timestamp":1791474677194,"version":"4.3.4"},"reference-count":71,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"20","license":[{"start":{"date-parts":[[2025,8,11]],"date-time":"2025-08-11T00:00:00Z","timestamp":1754870400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,10,20]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Pancreatic cancer is a lethal malignancy prone to gemcitabine resistance. The single-strand selective monofunctional uracil DNA glycosylase (SMUG1), which is responsible for initiating base excision repair, has been reported to predict the outcomes of different cancer types. However, the function of SMUG1 in pancreatic cancer is still unclear.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>\n                      Gene and protein expression of SMUG1 as well as survival outcomes were assessed by bioinformatic analysis and verified in a cohort from Fudan University Shanghai Cancer Center. Subsequently, the effect of SMUG1 on proliferation, cell cycle, and migration abilities of SMUG1 cells were detected\n                      <jats:italic toggle=\"yes\">in vitro<\/jats:italic>\n                      . DNA damage repair, apoptosis, and gemcitabine resistance were also tested. RNA sequencing was performed to determine the differentially expressed genes and signaling pathways, followed by quantitative real-time polymerase chain reaction and Western blotting verification. The cancer-promoting effect of forkhead box Q1 (FOXQ1) and SMUG1 on the ubiquitylation of myelocytomatosis oncogene (c-Myc) was also evaluated. Finally, a xenograft model was established to verify the results.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>SMUG1 was highly expressed in pancreatic tumor tissues and cells, which also predicted a poor prognosis. Downregulation of SMUG1 inhibited the proliferation, G1 to S transition, migration, and DNA damage repair ability against gemcitabine in pancreatic cancer cells. SMUG1 exerted its function by binding with FOXQ1 to activate the Protein Kinase B (AKT)\/p21 and p27 pathway. Moreover, SMUG1 also stabilized the c-Myc protein via AKT signaling in pancreatic cancer cells.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>SMUG1 promotes proliferation, migration, gemcitabine resistance, and c-Myc protein stability in pancreatic cancer via protein kinase B signaling through binding with FOXQ1. Furthermore, SMUG1 may be a new potential prognostic and gemcitabine resistance predictor in pancreatic ductal adenocarcinoma.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/cm9.0000000000003640","type":"journal-article","created":{"date-parts":[[2025,8,12]],"date-time":"2025-08-12T02:00:07Z","timestamp":1754964007000},"page":"2640-2656","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["SMUG1 promoted the progression of pancreatic cancer via AKT signaling pathway through binding with FOXQ1"],"prefix":"10.1097","volume":"138","author":[{"given":"Zijian","family":"Wu","sequence":"first","affiliation":[{"name":"Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai 200032, China"},{"name":"Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, China"},{"name":"Shanghai Pancreatic Cancer Institute, Shanghai 200032, China"},{"name":"Pancreatic Cancer Institute, Fudan University, Shanghai 200032, China"},{"name":"Department of General Surgery, Beijing Xuanwu Hospital, Capital Medical University, Beijing 100053, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai 200032, China"},{"name":"Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, China"},{"name":"Shanghai Pancreatic Cancer Institute, Shanghai 200032, China"},{"name":"Pancreatic Cancer Institute, Fudan University, Shanghai 200032, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Hua","sequence":"additional","affiliation":[{"name":"Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai 200032, China"},{"name":"Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, China"},{"name":"Shanghai Pancreatic Cancer Institute, Shanghai 200032, China"},{"name":"Pancreatic Cancer Institute, Fudan University, Shanghai 200032, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingyao","family":"Zhang","sequence":"additional","affiliation":[{"name":"Key Laboratory of Cancer and Microbiome, State Key Laboratory of Molecular Oncology, National Cancer Center, National Clinical Research Center for Cancer, Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiang","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai 200032, China"},{"name":"Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, China"},{"name":"Shanghai Pancreatic Cancer Institute, Shanghai 200032, China"},{"name":"Pancreatic Cancer Institute, Fudan University, Shanghai 200032, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Si","family":"Shi","sequence":"additional","affiliation":[{"name":"Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai 200032, China"},{"name":"Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, China"},{"name":"Shanghai Pancreatic Cancer Institute, Shanghai 200032, China"},{"name":"Pancreatic Cancer Institute, Fudan University, Shanghai 200032, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai 200032, China"},{"name":"Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, China"},{"name":"Shanghai Pancreatic Cancer Institute, Shanghai 200032, China"},{"name":"Pancreatic Cancer Institute, Fudan University, Shanghai 200032, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohui","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of General Surgery, Beijing Xuanwu Hospital, Capital Medical University, Beijing 100053, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianjun","family":"Yu","sequence":"additional","affiliation":[{"name":"Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai 200032, China"},{"name":"Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, China"},{"name":"Shanghai Pancreatic Cancer Institute, Shanghai 200032, China"},{"name":"Pancreatic Cancer Institute, Fudan University, Shanghai 200032, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai 200032, China"},{"name":"Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, China"},{"name":"Shanghai Pancreatic Cancer Institute, Shanghai 200032, China"},{"name":"Pancreatic Cancer Institute, Fudan University, Shanghai 200032, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,8,11]]},"reference":[{"key":"R1-20260303","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"R2-20260303","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"R3-20260303","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1097\/CM9.0000000000003225","article-title":"Burden of six major types of digestive system cancers globally and in China","volume":"137","author":"Zhou","year":"2024","journal-title":"Chin Med J"},{"key":"R4-20260303","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/s41571-018-0112-1","article-title":"Optimizing the outcomes of pancreatic cancer surgery","volume":"16","author":"Strobel","year":"2019","journal-title":"Nat Rev Clin Oncol"},{"key":"R5-20260303","doi-asserted-by":"crossref","first-page":"47","DOI":"10.21037\/cco-21-51","article-title":"Neoadjuvant therapy in resectable pancreatic cancer-is this the way forward?-a narrative review","volume":"10","author":"Perri","year":"2021","journal-title":"Chin Clin Oncol"},{"key":"R6-20260303","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/s41571-018-0114-z","article-title":"State-of-the-art strategies for targeting the DNA damage response in cancer","volume":"16","author":"Pili\u00e9","year":"2019","journal-title":"Nat Rev Clin Oncol"},{"key":"R7-20260303","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.molcel.2015.10.040","article-title":"Targeting the DNA damage response in cancer","volume":"60","author":"O\u2019Connor","year":"2015","journal-title":"Mol Cell"},{"key":"R8-20260303","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a012583","article-title":"Base excision repair","volume":"5","author":"Krokan","year":"2013","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"R9-20260303","doi-asserted-by":"crossref","first-page":"3118","DOI":"10.3390\/ijms21093118","article-title":"Inhibitors of DNA glycosylases as prospective drugs","volume":"21","author":"Mechetin","year":"2020","journal-title":"Int J Mol Sci"},{"key":"R10-20260303","doi-asserted-by":"crossref","first-page":"5003","DOI":"10.1021\/bi0273213","article-title":"Mammalian 5-formyluracil-DNA glycosylase. 2. Role of SMUG1 uracil-DNA glycosylase in repair of 5-formyluracil and other oxidized and deaminated base lesions","volume":"42","author":"Masaoka","year":"2003","journal-title":"Biochemistry"},{"key":"R11-20260303","doi-asserted-by":"crossref","first-page":"15835","DOI":"10.1074\/jbc.M807846200","article-title":"Mechanisms of base selection by human single-stranded selective monofunctional uracil-DNA glycosylase","volume":"284","author":"Darwanto","year":"2009","journal-title":"J Biol Chem"},{"key":"R12-20260303","doi-asserted-by":"crossref","first-page":"6016","DOI":"10.1093\/nar\/gks259","article-title":"Germline ablation of SMUG1 DNA glycosylase causes loss of 5-hydroxymethyluracil- and UNG-backup uracil-excision activities and increases cancer predisposition of Ung-\/-Msh2-\/- mice","volume":"40","author":"Kemmerich","year":"2012","journal-title":"Nucleic Acids Res"},{"key":"R13-20260303","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1007\/s10549-013-2769-6","article-title":"Single-strand selective monofunctional uracil-DNA glycosylase (SMUG1) deficiency is linked to aggressive breast cancer and predicts response to adjuvant therapy","volume":"142","author":"Abdel-Fatah","year":"2013","journal-title":"Breast Cancer Res Treat"},{"key":"R14-20260303","doi-asserted-by":"crossref","first-page":"23960","DOI":"10.18632\/oncotarget.25251","article-title":"Identification of different mutational profiles in cancers arising in specific colon segments by next generation sequencing","volume":"9","author":"Oliveira","year":"2018","journal-title":"Oncotarget"},{"key":"R15-20260303","doi-asserted-by":"crossref","first-page":"4109","DOI":"10.3760\/cma.j.issn.0366-6999.20131320","article-title":"A preliminary study of genes related to concomitant chemoradiotherapy resistance in advanced uterine cervical squamous cell carcinoma","volume":"126","author":"An","year":"2013","journal-title":"Chin Med J"},{"key":"R16-20260303","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1158\/0008-5472.CAN-06-2960","article-title":"5-Fluorouracil incorporated into DNA is excised by the Smug1 DNA glycosylase to reduce drug cytotoxicity","volume":"67","author":"An","year":"2007","journal-title":"Cancer Res"},{"key":"R17-20260303","doi-asserted-by":"crossref","first-page":"4346","DOI":"10.1158\/0008-5472.CAN-20-1353","article-title":"A transcriptome-wide association study identifies candidate susceptibility genes for pancreatic cancer risk","volume":"80","author":"Liu","year":"2020","journal-title":"Cancer Res"},{"key":"R18-20260303","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1200\/JCO.1997.15.6.2403","article-title":"Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: A randomized trial","volume":"15","author":"Burris","year":"1997","journal-title":"J Clin Oncol"},{"key":"R19-20260303","first-page":"53","article-title":"Personalized pancreatic cancer therapy: From the perspective of mRNA vaccine","volume":"9","author":"Huang","year":"2022","journal-title":"Mil Med Res"},{"issue":"Suppl 5","key":"R20-20260303","doi-asserted-by":"crossref","first-page":"v7","DOI":"10.1093\/annonc\/mdj941","article-title":"Cellular pharmacology of gemcitabine","volume":"17","author":"Mini","year":"2006","journal-title":"Ann Oncol"},{"key":"R21-20260303","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.cytogfr.2012.06.006","article-title":"Targeted destruction of the orchestration of the pancreatic stroma and tumor cells in pancreatic cancer cases: Molecular basis for therapeutic implications","volume":"23","author":"Kong","year":"2012","journal-title":"Cytokine Growth Factor Rev"},{"key":"R22-20260303","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1097\/MPA.0000000000001023","article-title":"Stroma \u2013 A double-edged sword in pancreatic cancer: A lesson from targeting stroma in pancreatic cancer with hedgehog signaling inhibitors","volume":"47","author":"Gu","year":"2018","journal-title":"Pancreas"},{"key":"R23-20260303","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1186\/s13045-021-01137-8","article-title":"Targeting Akt in cancer for precision therapy","volume":"14","author":"Hua","year":"2021","journal-title":"J Hematol Oncol"},{"key":"R24-20260303","doi-asserted-by":"crossref","first-page":"5034","DOI":"10.1073\/pnas.84.14.5034","article-title":"Molecular cloning of the Akt oncogene and its human homologues AKT1 and AKT2: Amplification of AKT1 in a primary human gastric adenocarcinoma","volume":"84","author":"Staal","year":"1987","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R25-20260303","doi-asserted-by":"crossref","first-page":"3803","DOI":"10.1200\/JCO.2014.59.0018","article-title":"Inhibition of the PI3K\/AKT\/mTOR pathway in solid tumors","volume":"34","author":"LoRusso","year":"2016","journal-title":"J Clin Oncol"},{"key":"R26-20260303","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s13046-018-0694-6","article-title":"14, 15-EET induces breast cancer cell EMT and cisplatin resistance by up-regulating integrin \u03b1v\u03b23 and activating FAK\/PI3K\/AKT signaling","volume":"37","author":"Luo","year":"2018","journal-title":"J Exp Clin Cancer Res"},{"key":"R27-20260303","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1038\/s41467-017-00450-6","article-title":"Convergent Akt activation drives acquired EGFR inhibitor resistance in lung cancer","volume":"8","author":"Jacobsen","year":"2017","journal-title":"Nat Commun"},{"key":"R28-20260303","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1038\/s41419-020-02998-6","article-title":"PI3K\/AKT pathway as a key link modulates the multidrug resistance of cancers","volume":"11","author":"Liu","year":"2020","journal-title":"Cell Death Dis"},{"key":"R29-20260303","doi-asserted-by":"crossref","first-page":"532","DOI":"10.3390\/cancers12030532","article-title":"Role of Akt activation in PARP inhibitor resistance in cancer","volume":"12","author":"Gallyas","year":"2020","journal-title":"Cancers (Basel)"},{"key":"R30-20260303","doi-asserted-by":"crossref","first-page":"5678","DOI":"10.1158\/0008-5472.CAN-21-0281","article-title":"LncRNA HIF1A-AS1 promotes gemcitabine resistance of pancreatic cancer by enhancing glycolysis through modulating the AKT\/YB1\/HIF1\u03b1 pathway","volume":"81","author":"Xu","year":"2021","journal-title":"Cancer Res"},{"key":"R31-20260303","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1038\/s12276-020-0390-4","article-title":"PROM2 promotes gemcitabine chemoresistance via activating the Akt signaling pathway in pancreatic cancer","volume":"52","author":"Li","year":"2020","journal-title":"Exp Mol Med"},{"key":"R32-20260303","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1038\/s41388-020-01634-z","article-title":"KNSTRN promotes tumorigenesis and gemcitabine resistance by activating AKT in bladder cancer","volume":"40","author":"Xiong","year":"2021","journal-title":"Oncogene"},{"key":"R33-20260303","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/pro.3978","article-title":"The BioGRID database: A comprehensive biomedical resource of curated protein, genetic, and chemical interactions","volume":"30","author":"Oughtred","year":"2021","journal-title":"Protein Sci"},{"key":"R34-20260303","doi-asserted-by":"crossref","first-page":"688","DOI":"10.20892\/j.issn.2095-3941.2019.0252","article-title":"The challenge of drug resistance in pancreatic ductal adenocarcinoma: A current overview","volume":"16","author":"Qui\u00f1onero","year":"2019","journal-title":"Cancer Biol Med"},{"key":"R35-20260303","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1002\/ijc.11679","article-title":"Resistance of pancreatic cancer to gemcitabine treatment is dependent on mitochondria-mediated apoptosis","volume":"109","author":"Schniewind","year":"2004","journal-title":"Int J Cancer"},{"key":"R36-20260303","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1056\/NEJMoa1011923","article-title":"FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer","volume":"364","author":"Conroy","year":"2011","journal-title":"N Engl J Med"},{"key":"R37-20260303","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1038\/nrc2523","article-title":"GammaH2AX and cancer","volume":"8","author":"Bonner","year":"2008","journal-title":"Nat Rev Cancer"},{"key":"R38-20260303","doi-asserted-by":"crossref","first-page":"201","DOI":"10.3390\/genes12020201","article-title":"Ablation of SMUG1 reduces cell viability and increases UVC-mediated apoptosis in hepatocarcinoma HepG2 cells","volume":"12","author":"An","year":"2021","journal-title":"Genes (Basel)"},{"key":"R39-20260303","doi-asserted-by":"crossref","first-page":"e1045","DOI":"10.1038\/cddis.2013.477","article-title":"Uracil DNA glycosylase (UNG) loss enhances DNA double strand break formation in human cancer cells exposed to pemetrexed","volume":"5","author":"Weeks","year":"2014","journal-title":"Cell Death Dis"},{"key":"R40-20260303","doi-asserted-by":"crossref","first-page":"12234","DOI":"10.1093\/nar\/gkaa1048","article-title":"Targeting OGG1 arrests cancer cell proliferation by inducing replication stress","volume":"48","author":"Visnes","year":"2020","journal-title":"Nucleic Acids Res"},{"key":"R41-20260303","doi-asserted-by":"crossref","first-page":"177","DOI":"10.3727\/096504019X15746768080428","article-title":"IOX-101 reverses drug resistance through suppression of Akt\/mTOR\/NF-\u03baB signaling in cancer stem cell-like, sphere-forming NSCLC cell","volume":"28","author":"Fayi","year":"2020","journal-title":"Oncol Res"},{"key":"R42-20260303","doi-asserted-by":"crossref","first-page":"51","DOI":"10.3892\/ijo.2016.3517","article-title":"Forkhead box Q1: A key player in the pathogenesis of tumors (review)","volume":"49","author":"Li","year":"2016","journal-title":"Int J Oncol"},{"key":"R43-20260303","doi-asserted-by":"crossref","first-page":"e55693","DOI":"10.1371\/journal.pone.0055693","article-title":"FOXQ1 promotes glioma cells proliferation and migration by regulating NRXN3 expression","volume":"8","author":"Sun","year":"2013","journal-title":"PLoS One"},{"key":"R44-20260303","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1158\/0008-5472.CAN-09-2161","article-title":"FOXQ1 is overexpressed in colorectal cancer and enhances tumorigenicity and tumor growth","volume":"70","author":"Kaneda","year":"2010","journal-title":"Cancer Res"},{"key":"R45-20260303","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1002\/hep.26735","article-title":"Forkhead box Q1 promotes hepatocellular carcinoma metastasis by transactivating ZEB2 and versicanv1 expression","volume":"59","author":"Xia","year":"2014","journal-title":"Hepatology"},{"key":"R46-20260303","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1002\/hep.27756","article-title":"Sox12, a direct target of FOXQ1, promotes hepatocellular carcinoma metastasis through up-regulating Twist1 and FGFBP1","volume":"61","author":"Huang","year":"2015","journal-title":"Hepatology"},{"key":"R47-20260303","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1158\/0008-5472.CAN-13-3029","article-title":"PDGFR\u03b1 and \u03b2 play critical roles in mediating FOXQ1-driven breast cancer stemness and chemoresistance","volume":"75","author":"Meng","year":"2015","journal-title":"Cancer Res"},{"key":"R48-20260303","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1038\/ncb3148","article-title":"Identification of molecular determinants of primary and metastatic tumour re-initiation in breast cancer","volume":"17","author":"Ross","year":"2015","journal-title":"Nat Cell Biol"},{"key":"R49-20260303","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.3748\/wjg.v28.i17.1781","article-title":"Forkhead Box q1 promotes invasion and metastasis in colorectal cancer by activating the epidermal growth factor receptor pathway","volume":"28","author":"Zhang","year":"2022","journal-title":"World J Gastroenterol"},{"key":"R50-20260303","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1007\/s10238-016-0443-0","article-title":"Differential role of Wnt signaling and base excision repair pathways in gastric adenocarcinoma aggressiveness","volume":"17","author":"Korourian","year":"2017","journal-title":"Clin Exp Med"},{"key":"R51-20260303","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/s41392-021-00828-5","article-title":"Targeting PI3K\/Akt signal transduction for cancer therapy","volume":"6","author":"He","year":"2021","journal-title":"Signal Transduct Target Ther"},{"key":"R52-20260303","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/s41573-022-00582-5","article-title":"Beyond PI3Ks: Targeting phosphoinositide kinases in disease","volume":"22","author":"Burke","year":"2023","journal-title":"Nat Rev Drug Discov"},{"key":"R53-20260303","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1016\/j.celrep.2019.07.040","article-title":"SMUG1 promotes telomere maintenance through telomerase RNA processing","volume":"28","author":"Kroustallaki","year":"2019","journal-title":"Cell Rep"},{"key":"R54-20260303","doi-asserted-by":"crossref","first-page":"e19","DOI":"10.1017\/S1462399408000744","article-title":"P21 and p27: Roles in carcinogenesis and drug resistance","volume":"10","author":"Abukhdeir","year":"2008","journal-title":"Expert Rev Mol Med"},{"key":"R55-20260303","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/0092-8674(94)90573-8","article-title":"p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21","volume":"78","author":"Toyoshima","year":"1994","journal-title":"Cell"},{"key":"R56-20260303","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/0092-8674(94)90572-X","article-title":"Cloning of p27Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals","volume":"78","author":"Polyak","year":"1994","journal-title":"Cell"},{"key":"R57-20260303","doi-asserted-by":"crossref","first-page":"8128","DOI":"10.1038\/sj.onc.1207994","article-title":"Tumor suppressor functions for the Cdk inhibitor p21 in the mouse colon","volume":"23","author":"Poole","year":"2004","journal-title":"Oncogene"},{"key":"R58-20260303","doi-asserted-by":"crossref","first-page":"9089","DOI":"10.1073\/pnas.96.16.9089","article-title":"p21(WAF1\/Cip1) functions as a suppressor of malignant skin tumor formation and a determinant of keratinocyte stem-cell potential","volume":"96","author":"Topley","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R59-20260303","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/S0092-8674(00)81237-4","article-title":"Mice lacking p27(Kip1) display increased body size, multiple organ hyperplasia, retinal dysplasia, and pituitary tumors","volume":"85","author":"Nakayama","year":"1996","journal-title":"Cell"},{"key":"R60-20260303","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/S0092-8674(00)81238-6","article-title":"Enhanced growth of mice lacking the cyclin-dependent kinase inhibitor function of p27(Kip1)","volume":"85","author":"Kiyokawa","year":"1996","journal-title":"Cell"},{"key":"R61-20260303","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/24179","article-title":"The murine gene p27Kip1 is haplo-insufficient for tumour suppression","volume":"396","author":"Fero","year":"1998","journal-title":"Nature"},{"key":"R62-20260303","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1038\/nm761","article-title":"PKB\/Akt phosphorylates p27, impairs nuclear import of p27 and opposes p27-mediated G1 arrest","volume":"8","author":"Liang","year":"2002","journal-title":"Nat Med"},{"key":"R63-20260303","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/35060032","article-title":"Cytoplasmic localization of p21Cip1\/WAF1 by Akt-induced phosphorylation in HER-2\/neu-overexpressing cells","volume":"3","author":"Zhou","year":"2001","journal-title":"Nat Cell Biol"},{"key":"R64-20260303","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1038\/s41418-019-0363-0","article-title":"The MAP3K13-TRIM25-FBXW7\u03b1 axis affects c-Myc protein stability and tumor development","volume":"27","author":"Zhang","year":"2020","journal-title":"Cell Death Differ"},{"key":"R65-20260303","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1080\/15384047.2021.2017223","article-title":"Target c-Myc to treat pancreatic cancer","volume":"23","author":"Ala","year":"2022","journal-title":"Cancer Biol Ther"},{"key":"R66-20260303","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.3390\/cancers12041050","article-title":"DNA damage\/repair management in cancers","volume":"12","author":"Alhmoud","year":"2020","journal-title":"Cancers (Basel)"},{"key":"R67-20260303","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1038\/sj.emboj.7600689","article-title":"C --> T mutagenesis and gamma-radiation sensitivity due to deficiency in the Smug1 and Ung DNA glycosylases","volume":"24","author":"An","year":"2005","journal-title":"EMBO J"},{"key":"R68-20260303","doi-asserted-by":"crossref","first-page":"4008","DOI":"10.1016\/j.molcel.2021.08.016","article-title":"REV1-Pol\u03b6 maintains the viability of homologous recombination-deficient cancer cells through mutagenic repair of PRIMPOL-dependent ssDNA gaps","volume":"81","author":"Taglialatela","year":"2021","journal-title":"Mol Cell"},{"key":"R69-20260303","doi-asserted-by":"crossref","first-page":"238","DOI":"10.7150\/jca.27103","article-title":"Association of SMUG1 SNPs in intron region and linkage disequilibrium with occurrence of cervical carcinoma and HPV infection in Chinese population","volume":"10","author":"Ye","year":"2019","journal-title":"J Cancer"},{"key":"R70-20260303","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.molcel.2012.11.010","article-title":"The human base excision repair enzyme SMUG1 directly interacts with DKC1 and contributes to RNA quality control","volume":"49","author":"Jobert","year":"2013","journal-title":"Mol Cell"},{"key":"R71-20260303","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1038\/345458a0","article-title":"Telomeres shorten during ageing of human fibroblasts","volume":"345","author":"Harley","year":"1990","journal-title":"Nature"}],"container-title":["Chinese Medical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/CM9.0000000000003640","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T19:01:03Z","timestamp":1772564463000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/CM9.0000000000003640"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,11]]},"references-count":71,"journal-issue":{"issue":"20","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/cm9.0000000000003640","relation":{},"ISSN":["0366-6999","2542-5641"],"issn-type":[{"value":"0366-6999","type":"print"},{"value":"2542-5641","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,11]]},"assertion":[{"value":"2024-12-27","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}}]}}